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Abstract
Background: Macrophage are specialized cells that contributes to the removal of detrimental contents via
phagocytosis. Lipid accumulation in macrophages, whether from phagocytosis of dying cells or from circulating
oxidized low-density lipoproteins, alters macrophage biology and functionality. It is known that carnitine palmitoyl
transferase 1-a (CPT1a) gene encodes an enzyme involved in fatty acid oxidation and, therefore, lipid content.
However, the potential of CPT1a to activate macrophage phagocytic function have not been elucidated.
Methods: Using a murine macrophage cell line, RAW264.7, we determine if intracellular accumulation of 7-
ketocholesterol (7-KC) modulates macrophage phagocytic function through CPT1a gene expression. In addition,
the effects of CPT1a genetic modification on macrophage phenotype and phagocytosis has been studied.
Results: Our results revealed that CPT1a gene expression decreased by the accumulation of 7-KC at the higher
dose of 7-KC. This was concomitant with an impair ability to phagocytize bioparticles and an inflammatory
phenotype. GW3965 treatment, which have shown to facilitate the efflux of cholesterol, eliminated the intracellular
lipid droplets of 7-KC-laden macrophages, increased the gene expression of CPT1a, diminished the gene expression
of the inflammatory marker iNOS and restored macrophage phagocytosis. Furthermore, CPT1a Knockdown per se
was detrimental for macrophage phagocytosis whereas transcriptional activation of CPT1a heightened the uptake
of bioparticles.
Conclusions: Altogether, our findings indicate that downregulation of CPT1a by lipid content modulates
macrophage phagocytosis and inflammatory phenotype.
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Background
Macrophages are professional phagocytes aimed to
remove pathogens, small particles as well as damaged or
dead cells [1]. If macrophage phagocytosis is compro-
mised, neighboring cells will engulf apoptotic cells at a
much slower rate, prolonging exposure to cytotoxic
contents, thereby perpetuating an inflammatory state [2].
As macrophages take up lipoproteins acquired due to
the phagocytosis of dying cells, they have evolved mech-
anisms for eliminating cholesterol from the cell. If excess
cholesterol is not eliminated from macrophages, the
transformation into foam cells could occur. Such foam
cells are a hallmark of the atherosclerotic lesion contrib-
uting to the development and rupture of atherosclerotic
plaques [3]. In addition, macrophages also internalize
low-density lipoproteins (LDL), very low-density lipopro-
teins (VLDL) and oxidized low-density lipoprotein
(oxLDL) via phagocytosis, macropinocytosis or scaven-
ger receptors such as CD36 [4]. Once internalized, lipids
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are degraded in the lysosome by lysosomal acid lipase
[5] into free cholesterol and fatty acids [6]. In the
cytosol, fatty acids are activated to acyl-coenzyme A (acyl-
CoA) by acyl-CoA synthetases, either for lipid biosynthesis
or for mitochondrial fatty acid β-oxidation (FAO) [7]. As
the mitochondrial membrane is impermeable to acyl-
CoAs, the carnitine shuttle manages their transport into
the mitochondria. First, on the outer mitochondrial
membrane, the enzyme carnitine palmitoyltransferase-1
(CPT1) converts acyl-CoA to acylcarnitine. Next, this
complex is translocated across the inner mitochondrial
membrane to the mitochondrial matrix by the carnitine-
acylcarnitine translocase and finally reconverted back to
acyl-CoA by the enzyme CPT2 of the peripheral inner
mitochondrial membrane [8]. It has been shown that the
expression of a permanently active mutant of CPT1a en-
hanced fatty acid oxidation in macrophages and reduced
pro-inflammatory cytokines [9], suggesting that inducing
FAO in foam cells could be of therapeutic potential. It
seems that the expression of CPT1a has an influence on
inflammation and on the elimination of intracellular lipids.
However, the relationship between CPT1a, foam cells
formation and macrophage phagocytic function remains
unclear.
Herein 7-KC was used to induce high lipid load mac-
rophages, since is among the most abundant oxysterol
to be found in oxLDL [10] and atherosclerotic plaques
[11]. We converted RAW264.7 into foam cells by 7-KC
accumulation and examined the alterations in CPT1a
gene expression, modifications on macrophage inflam-
matory phenotype and the uptake of pHrodo bioparti-
cles. In addition, the direct effects of CPT1a expression
on macrophage phenotype and phagocytosis were
studied throughout genetic strategies of knockdown and
transcriptional activation of CPT1a.
Our results reveal that macrophage phagocytosis and
inflammatory phenotype are dependent on intracellular
lipid accumulation and CPT1a expression, and that the
direct downregulation of CPT1a by high lipid content in
macrophages is a key modulator of this process.
Methods
Materials
Dulbecco’s Modified Eagle Medium/Nutrient Mixture F-
12 with GlutaMAX (DMEM/F12 +GlutaMAX), Heat
Inactivated Fetal Bovine Serum (FBS) and Penicillin/
Streptomycin were obtained from Gibco (Madrid, Spain).
Adenovirus vector with a short hairpin RNA target to
CPT1a and the control non-targeted were generated by
Galapagos NV (Mechelen, Belgium). Plasmid Transfection
Medium, UltraCruz Transfection Reagent, Control
CRISPR Activation Plasmid and CPT1 CRISPR Activation
Plasmid were obtained from Santa Cruz Biotechnology,
Inc. (Heidelberg, Germany). Live cell image solution and
pHrodo Green E. coli BioParticles conjugate were
purchased from Molecular Probes (Madrid, Spain). 7-
Ketocholesterol (5-Cholesten-3β-ol-7-one) and GW3965
hydrochloride were obtained from Sigma-Aldrich
(Madrid, Spain). C75 (4-Methylene-2-octyl-5-oxotetrahy-
drofuran-3-carboxylic acid) was purchased from Santa
Cruz Biotechnology, Inc. (Heidelberg, Germany). 7-
ketocholesterol stock solution was prepared by dissolving
the chemical compound in 100% ethanol at concentration
of 5 mg/ml. C75 and GW3965 stock solutions were pre-
pared in dimethyl sulfoxide (DMSO) at a concentration of
10mg/ml and 32,34mM respectively. Designed primers
were bought from Life Technologies (Madrid, Spain).
Cell culture and treatments
The murine macrophage cell line RAW264.7 (obtained
from the European Collection of Authenticated Cell Cul-
tures) was cultured in DMEM/F12 + GlutaMAX supple-
mented with 10% FBS and 1% antibiotics (100 Units/ml
penicillin and 100 μg/ml streptomycin). Cells were main-
tained in a humidified incubator at 37 °C under 5% CO2
and passaged twice a week reaching 80% confluence by
cell scraping. Cells from passage 10–15 were culture in
12-well plate and allow to grow for 24 h until reach the
desired confluence for each procedure.
RAW264.7 grown to 60–80% were incubated with 7-KC
at 5 μg/ml and 10 μg/ml for 24 h in DMEM/F12 +Gluta-
MAX supplemented with 10% FBS and 1% antibiotics.
GW3965 treatment was at 3 μM for 16 h following 7-KC
incubation and C75 pre-treatment was administrated at
10μg/ml for 2 h before 7-KC incubation. Control cells
were incubated with the corresponding vehicles.
shRNA adenoviral transduction
RAW264.7 macrophages grown to 80% confluence were
transduced with adenovirus vector carrying a short hair-
pin targeting CPT1a with a multiplicity of infection of
150 in antibiotic free DMEM/F12 + GlutaMAX supple-
mented with 2% FBS and 1 μl of poly-l-lysine for 24 h. A
non-targeted short hairpin RNA was used as negative
control. Cells were used 24 h post transduction.
CRISPR activation plasmid transfection
RAW264.7 macrophages were grown to 60–80% conflu-
ence in antibiotic free DMEM/F12 + GlutaMAX supple-
mented with 10% FBS and transfected with CPT1a
CRISPR activation plasmid (sc-419786-act) and control
CRISPR activation plasmid (sc-437,275) according to the
manufacturer’s protocol. In brief, 0.5 μg of plasmid DNA
and 5 μl of UltraCruz transfection reagent (sc-395739)
were used for each transfection. After 24 h, the relevant
assays were performed.
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Oil red O staining (ORO)
To prepare the ORO working solution, 3 parts of 0.3%
ORO was mixed with 2 parts of distillated water, allowed
to settle for 10 min and filtered before use. Cells were
fixed with 10% formalin for 10 min, washed with PBS,
rinsed with 60% isopropanol for 5 min and stained with
ORO working solution for 5 min. Nuclei were counter-
stained with hematoxylin. Images were acquired in a
Zeiss Axiophot microscope and analyzed using ImageJ2.
Quantitative Oil Red O staining was performed by eluting
the dye with isopropanol. Briefly, the dye was eluted from
the stained cells using 500 μl of 100% isopropanol for 20
min in an orbital shaker. Then, two aliquots of 200 μl were
transferred to a 96-well plate and the absorbance was read
at 510 nm in a Multiskan Sky Microplate Spectrophotom-
eter (Thermo Fisher Scientific, USA).
Phagocytosis assay
One vial of pHrodo Green E. coli BioParticles conjugate
(P35366) was suspended in 2ml of LCIS (Live Cell Im-
aging Solution, A14291DJ) at 1mg/ml, thoroughly vor-
texed and sonicated following manufacturer’s instructions.
Bioparticles were tittered to a final concentration of 55 μg/
ml per well for the assay. After each experiment,
RAW264.7 cells were incubated with pHrodo Green E.
coli BioParticles diluted in LCIS at 55 μg/ml for 90min at
37 °C. Cell imaging was performed on Leica CTR 4000
microscope and fluorescence intensity was measured
using a Spectramax Gemini XS spectrofluorometer plate
reader (Molecular Devices, Sunnyvale, CA) at excitation
485 nm and emission 530 nm. As indicated by the manu-
factures, net phagocytosis was calculated by subtracting
the average fluorescence intensity of the no-cell negative
control wells from all sample wells. Net phagocytosis data
are presented as the change level relative to the observed
in the control untreated cells.
Quantitative real-time polymerase chain reaction (qPCR)
Total RNA was isolated using the RNeasy Mini kit (Qia-
gen). A total among of 1μg RNA was reverse transcribed
into cDNA using the iScript cDNA synthesis Kit (Bio-Rad).
qPCR assay was performed on a Bio-Rad CFX96 Touch
Real Time PCR detection system with SooAdvanced
Universal SYBR Green Supermix (Bio-Rad). Sequences of
specific primers are listed in Table 1. The housekeeping
gene GAPDH was used as internal control. Reactions were
carried in triplicate. qPCR data were analyzed using the
relative mRNA expression method calculated by the 2-ΔΔCT
equation, where ΔCT=Ct (target gene) – Ct (gapdh) and
ΔΔCT=ΔCt (treated) – ΔCt (untreated). All data are presented
as mRNA expression levels relative to untreated control
values.
Statistical analysis
All data were reported as mean ± SE of at least three in-
dependent experiments, each experiment with an n = 3.
Unpaired t-test was used to compare means among two
groups. Differences in values were considered to be sta-
tistically significant if P < 0.05. Statistical analyses were
performed with GraphPad Prism 8.0 software.
Results
Intracellular lipid content modifies macrophage
phenotype, CPT1a gene expression and phagocytosis
To understand the effect of intracellular lipid content on
macrophage phenotype, CPT1a expression and phago-
cytosis, RAW264.7 murine macrophages were incubated
with 7-KC at 5 and 10 μg/ml for 24 h as previously re-
ported [12] to obtain foam cells. Additionally, to test the
effect of lipid reduction in 7-KC overloaded macro-
phages, lipid efflux was promoted by treatment with
3 μM of GW3965 (GW) for 16 h following 7-KC admin-
istration. Control cells were incubated with ethanol for
24 h following DMSO for 16 h. We evaluated the intra-
cellular lipid droplets stained by oil red-o, mRNA
expression levels by qPCR and the phagocytosis by
pHrodo Green E. coli bioparticles.
As shown in Fig. 1a, b, the incubation with 7-KC in
macrophages, leaded to an accumulation of intracellular
lipid droplets that was more pronounced when exposed
to 7-KC at 10 μg/ml whereas GW treatment diminished
this accumulation of lipids, as represented by a decrease
in oil red o-stained lipids.
As shown in Fig. 1c, CPT1a mRNA expression remained
unmodified when cells were exposed to 7-KC at 5 μg/ml
(7-KC 5) but was significantly down-regulated at the
Table 1 Primers sequences used for qPCR





NLRP3 Assay ID: qMmuCID0010647. PrimePCR™ SYBR® Green Assay (Bio-Rad).
GAPDH glyceraldehyde 3-phosphate dehydrogenase, CPT1a carnitine palmitoyl transferase 1-a, CD36 cluster of differentiation CD36, iNOS inducible nitric oxide
synthase, NLRP3 NOD-like receptor pyrin domain-containing-3
Calle et al. Lipids in Health and Disease          (2019) 18:215 Page 3 of 10
dose of 10 μg/ml (7-KC 10). In contrast, GW treatment
significantly up-regulated CPT1a expression in both 7-KC
concentrations. These results suggested that CPT1a ex-
pression increases when the intracellular lipid accumula-
tion diminish. Similarly, CD36 mRNA expression was up-
regulated after GW treatment, also regardless of the initial
dose of 7-KC. Thus, a decrease of lipid content not only
increases the expression of CPT1a but also of the scaven-
ger receptor CD36. Moreover, 7-KC-induced intracellular
lipid accumulation shifted macrophage towards a pro-
inflammatory phenotype by enhancing iNOS mRNA
expression and treatment with GW reversed this
effect (Fig. 1d). Hence, a decline in inflammatory
phenotype is concomitant with a reduction in lipid
content and CPT1a gene expression is involved.
NLRP3 (Fig. 1d) also heightened as a consequence of
GW treatment, suggesting that CPT1a expression and
NLRP3 are related.
Fig. 1 Dose-dependent effects of 7-Ketocholesterol on macrophage lipid content, phenotype and phagocytosis. RAW264.7 were incubated with
7-ketocholesterol at 5 μg/ml (7-KC 5) and 10 μg/ml (7-KC 10) for 24 h, following treatment with 3 μM of GW3965 for 16 h (7-KC 5 + GW) and (7-KC
10 + GW). As control, cells were incubated with ethanol for 24 h following DMSO for 16 h (Control). a Representative Oil Red O staining images,
scale bar 20 μm. b Quantification of oil red by determining absorbance at 510 nm after elution with isopropanol. c, d qPCR analysis of mRNA
expression levels represented relative to control of the experiments (c) CPT1a and CD36 (d) iNOS and NLRP3. e Net Phagocytosis of 55 μg/ml
pHrodo Green E. ecoli bioparticles conjugate for 90 min measured by spectrofluorometer at excitation 485 nm and emission 530 nm. f
Representative images of pHrodo uptake capture by fluorescence microscopy, scale bar 20 μm. Data are represented as means ±SEM of 3
independent experiments with n = 3 each. *≤ 0.05 versus Control; α≤ 0.05 versus 7-KC 5; β≤ 0.05 versus 7-KC 10
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In order to evaluate macrophage phagocytic ability,
RAW264.7 were incubated with 55 μg/ml of pHrodo
Green E. coli bioparticles for 90min at 37 °C. As shown in
Fig. 1e, f, only macrophages exposed at 7-KC10 signifi-
cantly lessened the uptake of pHrodo bioparticles. Thus,
7-KC impairs phagocytosis at the dose in which CPT1a is
decreased. GW treatment had no effect on phagocytosis
in cells exposed to 7-KC 5 (7KC5 +GW), however it did
increase the uptake of pHrodo bioparticles to basal condi-
tions in cells previously incubated with 7-KC10 (7KC10 +
GW). Taken together, these results reveal that phagocyt-
osis is compromised by intracellular lipid content only if
CPT1a expression is decreased.
Thereafter, we pharmacologically target CPT1a with the
compound C75 which is a CPT1 activity inhibitor (Bentebi-
bel et al. 2006). The above findings presented that 7-KC at
the concentration of 10 μg/ml resulted in a decrease of
CPT1 expression; therefore, we incubated RAW264.7 with
7-KC at 10 μg/ml for 24 h in the absence or presence of
C75 pre-treatment at 10 μg/ml for 2 h. Control cells were
incubated with DMSO for 2 h following ethanol for 24 h.
Figure 2a, show a decreased expression of CPT1a by 7-
KC10 treatment, which in this case is more pronounced
than that observed in Fig. 1c, this is because the experi-
mental conditions of the control group are different in the
two experiments and this influences the expression of
CPT1a, therefore the same CPT1a expression value in-
duced by 7-KC10 gives rise to different expressions rela-
tive to controls in the two experiments.
As shown in Fig. 2a, C75 pre-treatment maintained the
down-regulated expression of CPT1a induced by 7-KC.
When the lipid content was evaluated by oil red-o stain-
ing, C75 pre-treatment significantly heightened lipid drop-
lets respect 7-KC exposure alone (Fig. 2c). Indicating that
a decrease in CPT1a activity due to C75 promotes a
higher accumulation of neutral lipids in the cytosol, but
was unable to modify CPT1a expression. In addition, C75
pre-treatment did not change by any means the impaired
phagocytosis produced by an increased intracellular lipid
content due to 7-KC exposure (Fig. 2d, e). In addition,
C75 administration to control cells did not modify any of
the measured parameters. Taken together, these observa-
tions suggest that increases in lipid droplets accumulation
(as occurs in C75 + 7KC-10 with respect to 7KC-10) not
always lead to a decrease phagocytosis and that there are
more factors that modulate it.
CPT1a knockdown impairs phagocytosis and stimulates
inflammation
In order to evaluate the role of CPT1a on macrophage
phenotype and phagocytosis, RAW264.7 cell line was
transduced with either adenovirus encoding a short hair-
pin CPT1a-target (Adsh CPT1a) or a non-target short
hairpin (AdshCtrl) for 24 h and transduction efficacy
was confirmed by qPCR. As control, un-transduced cells
were used.
As shown in Fig. 3a, CPT1a Knockdown on macro-
phages did not modify CD36 expression respect to un-
transduced cells but it did promote an up-regulation of
the pro-inflammatory marker iNOS (Fig. 3b), suggesting
that CPT1a expression may be needed to avoid a pro-
inflammatory phenotype. Interestingly, CPT1a silencing
provoked a decrease on NLRP3 expression (Fig. 3b).
To evaluate macrophages intracellular lipid content, post-
transduced cells were stained with Oil Red O. As shown in
Fig. 3c, d, CPT1a knockdown macrophages exhibited in-
creased intracellular lipid droplets compared to AdshCtrl
and un-transduced cells (Control). In addition, the phago-
cytic function demonstrated that CPT1a gene silencing
leaded to a significant decrease in phagocytosis (Fig. 3e, f).
Overall, results indicate that CPT1a knockdown pro-
motes an increase in lipid accumulation and in the pro-
inflammatory marker iNOS associated to an impaired
phagocytosis and down-regulation of NLRP3.
CPT1a overexpression decreases lipid content and
stimulates phagocytosis
Furthermore, to elucidated the effect of CPT1a expres-
sion on lipid accumulation and phagocytosis ability we
transfected RAW264.7 cells with either CPT1a Crispr
activation plasmid (CPT1a Crispr) or Control Crispr ac-
tivation plasmid (Control-Crispr) for 24 h.
As shown in Fig. 4a, qPCR analysis showed that
macrophages transfected with CPT1a plasmid had an in-
crease in CPT1a mRNA expression respect to Control
Crispr cells. mRNA expressions of CD36 and iNOs
showed no significantly difference between both trans-
duced cells (Fig. 4a, b), while significant increases were
observed in NLRP3 expression. As shown in Fig. 4b, the
use of a control crisp activation plasmid induces an
iNOS expression that is three times higher than the con-
trol value, indicating a non-specific effect of the plasmid,
but the use of the control crisp activation plasmid affects
neither NPLR3 expression nor CPT1a expression.
The imaging of neutral lipids by oil red displayed an
accumulation of lipid droplets in the cytosol of Control
Crispr whereas the lipid content in on macrophages ex-
pressing CPT1a was significantly lesser (Fig. 4c, d). The
ability to uptake pHrodo bioparticles was enhanced in
CPT1a Crisp regard to Control-Crispr (Fig. 4e, f).
Together these findings indicated that CPT1 expression
is not only related to the accumulation of intracellular
lipid droplets but is also involved in the macrophage
phagocytic function.
Discussion
Macrophages are well known for their plasticity, adapt-
ing their phenotype in response to internal and
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environmental cues. The most recognized nomenclature
derives from in vitro stimulation and classifies macro-
phages into classically activated or pro-inflammatory
(M1) and alternatively activated or anti-inflammatory
(M2) macrophages. Although in vivo, this dichotomous
M1/M2 classification system may not apply since the
combination of stimulus are more complex, as demon-
strated in human monocyte-derived macrophages by
adding other conditions apart from the standard M1 or
M2 polarization such as high-density lipoproteins
Fig. 2 7-Ketocholesterol impairs phagocytosis through CPT1a gene expression. RAW264.7 were incubated with 7-ketocholesterol at 10 μg/ml (7-
KC10) for 24 h in the absence or presence of C75 pre-treatment at 10 μg/ml for 2 h (C75 + 7-KC10). (Control) cells were incubated with DMSO for
2 h before ethanol incubation for 24 h . (C75) cells were incubated with C75 at 10 μg/ml for 2 h before ethanol incubation for 24 h. a CPT1a
mRNA expression determined by qPCR, presented as relative to controlsb Representative Oil Red O staining images, scale bar 20 μm. c
Quantification of oil red by determining absorbance at 510 nm after elution with isopropanol. d Net phagocytosis of 55 μg/ml pHrodo Green E.
coli bioparticles conjugate for 90 min measured by spectrofluorometer at excitation 485 nm and emission 530 nm. e Representative images of
pHrodo uptake capture by fluorescence microscopy, scale bar 20 μm. Data are represented as means ±SEM of 4 independent experiments. *≤
0.05 versus Control; β≤ 0.05 versus 7-KC 10.
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(HDL), free fatty acids or a combination of stimuli associ-
ated with chronic inflammation [13]. Hence, a model were
macrophages display a mixed phenotype rather than a M1
versus M2 usual phenotype, is most likely [14].
In our study, the accumulation of intracellular lipids
induced by 7-KC stimulated the mRNA expression of
the pro-inflammatory marker iNOS consistent with pre-
vious reports of 7-KC as an pro-inflammatory inductor
[15]. Notably, only at the higher concentration of 7-KC,
iNOS up-regulation is concomitant with CPT1a down-
regulation whereas CD36 and NLRP3 mRNA expression
remained unchanged.
The compound GW3965, a synthetic liver X receptor
(LXR) ligand, activates the transcription of genes encod-
ing ATP-binding cassette transporters A1 and G1 which
have shown to facilitate the efflux of cholesterol [16] and
7-KC [17] in macrophages xs. Additionally, it has been
shown that the synthetic ligand-activation of LXR by
GW inhibits the induction of inflammatory genes in re-
sponse to M1 stimuli on thioglycollate-elicited mouse
Fig. 3 CPT1a Knockdown is involved in macrophage phenotype and phagocytosis. RAW264.7 were transduced with adenovirus encoding a short
hairpin RNA targeting CPT1a (AdshCPT1a) and a non-target short hairpin RNA (AdshCtrl) for 24 h, as control un-transfected macrophages were
used (Control). a, b mRNA expression determined by qPCR of (a) CPT1a and CD36 (b) iNOS and NLRP3. c Representative Oil Red O staining
images, scale bar 20 μm. d Quantification of oil red o staining images. e Net Phagocytosis of 55 μg/ml pHrodo Green E. ecoli bioparticles
conjugate for 90 min measured by spectrofluorometer at excitation 485 nm and emission 530 nm. f Representative images of pHrodo uptake
capture by fluorescence microscopy, scale bar 50 μm. Data are represented as means ±SEM of 4–5 independent experiments with n = 3 each.
*≤ 0.05 versus Control; #≤ 0.05 versus AdshCtrl
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peritoneal macrophages [18]. When we treated 7-KC
laden macrophage with GW, as expected, the intracellu-
lar lipid content decreased and the inflammatory state
reverted. Interestingly, CPT1a mRNA expression in-
creased in conjunction with CD36 and NLRP3. Reports
reveal that M2 macrophages has an increase expression
of scavenger receptor CD36 [19]. So, there seems to be a
correlation between the stimulation of CPT1a expression
and a switch of M1 phenotype towards M2. Similarly,
the uptake of pHrodo bioparticles by lipid-laden macro-
phages changed in a similar pattern of those observed in
CPT1a expression, as phagocytosis impaired when
CPT1a decreased, due to the excess in lipid content, and
recovered when CPT1a increases, after lipid efflux by
GW.
Cellular metabolism also contributes to macrophage
activation, as it has been noticed that M1 rely on gly-
colysis whereas M2 seems to prefer fatty acid oxidation
and glutamine metabolism as energy source [20–22]. It
appears that the presence or absence of lipids has a great
impact on macrophage biology, since macrophages have
been implicated in the pathogenesis of diseases where
lipid homeostasis is perturbed such as atherosclerosis,
non-alcoholic fatty liver disease [3] and chronic kidney
Fig. 4 CPT1a overexpression decreases lipid content and stimulates phagocytosis. RAW264.7 were transfected with either CPT1a CRISPR activation
plasmid (CPT1a Crispr) or Control CRISPR activation plasmid (Control Crispr) for 24 h. a, b mRNA expression measure by qPCR of (a) CPT1a and
CD36 (b) iNOS and NLRP3. c Representative Oil Red O staining images, scale bar 20 μm. d Quantification of oil red o staining images. e Net
Phagocytosis of 55 μg/ml pHrodo Green E. ecoli bioparticles conjugate for 90 min measured by spectrofluorometer at excitation 485 nm and
emission 530 nm. f Representative images of pHrodo uptake capture by fluorescence microscopy, scale bar 50 μm. All data are represented as
means ±SEM of 3 independent experiments with n = 3 each. *≤ 0.05 versus Control; # ≤ 0.05 versus Control- Crisp
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disease [23]. Lipids from LDL, VLDL and oxLDL taken
up by macrophages are degraded through lysosomal lip-
olysis into free cholesterol and fatty acids and eventually
exported to HDL or transported into the mitochondria,
respectively. Fatty acids are transported to the mitochon-
dria via carnitine shuttle system for energy production
through FAO, whereby CPT1 is consider to be the rate-
limiting enzyme in FAO [24]. It has been reported, that
the expression of a malonyl-CoA insensitive form of
CPT1A on RAW264.7 macrophages, not only enhanced
FAO but also reduced the production of pro-
inflammatory cytokines from palmitate-induction [9]. It
seems interesting to determine whether FAO has a cor-
relative or causal role in macrophage polarization.
In our study we use the compound C75, since it has
been shown to be converted within the cell to its
coenzyme-A derivative (C75-CoA), which directly in-
hibits CPT1 activity [25, 26]. When we pharmacologic-
ally targeted CPT1a with C75 before 7-KC exposure, the
accumulation of lipid droplets significantly increased re-
spect to 7KC-overload macrophages, as a response of
the enzymatic activity inhibition of CPT1, although
CPT1a expression and phagocytosis remained attenu-
ated. These findings suggest that modifications in FAO
may not affect CPT1a expression or phagocytosis.
Our results found, that the conversion of macrophages
into foam cells provoked a deficient uptake of bioparti-
cles when CPT1a expression was down-regulated. More-
over, the formation of foam cells was accompanied by
an inflammatory phenotype and it is known that choles-
terol crystals induce the activation of NLRP3 inflamma-
some [27]. Recently, it has been proved that intracellular
lipid overload derived from excessive cholesterol-rich
myelin, actives NLRP3 inflammasome [28]. By the con-
trary, in our study, the reduction of 7-KC-overload in
the cytosol by GW-treatment potentiated the expression
of the inflammasome related gene NLRP3.
The fact that other authors have observed a NOX4
dependent inactivation of CPT1a leading to a reduction
in NLRP3 activation in macrophages [29] could help to
explain our findings, since GW-treatment stimulate an
increased CPT1a expression that could be responsible
for the increased expression NLRP3. Moreover, CPT1a
knockdown correlated with a decrease in NLRP3 expres-
sion, hence, a direct relationship could be suggested.
Furthermore, strategies on CPT1a genetic modification
confirmed the above findings. In CPT1a knockdown
macrophages, lipid droplets were found increased, to-
gether with up-regulated iNOS expression leading to an
inflammatory state where phagocytosis was found to be
impaired. In accordance, CPT1a overexpression by
Crispr activation maintained a basal content of lipid
droplets with an improved phagocytosis respect Control
Crispr plasmid.
Although we did not find a shift towards an anti-
inflammatory phenotype when CPT1a was overex-
pressed, since no significant differences were found in
CD36 and iNOS; thus, indicating that macrophages
phagocytosis is not a simple anti- or pro-inflammatory
response, highlighting their heterogeneity.
Conclusion
7-KC10 is able to downregulate CPT1a expression lead-
ing to an inflammatory phenotype and phagocytosis im-
pairment. Whereas lipid content reduction stimulated
CPT1a expression, reducing the inflammatory phenotype
and improving phagocytosis.
Altogether, our findings reveal a causative link between
CPT1a expression and macrophage phagocytic ability.
Our results reveal that downregulation of CPT1a by lipid
content modulates macrophage phagocytosis and inflam-
matory phenotype.
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